Filing Details
- Accession Number:
- 0001437749-23-034227
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-12 17:05:17
- Reporting Period:
- 2023-12-08
- Accepted Time:
- 2023-12-12 17:05:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365737 | W George Lemaitre | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-12-11 | 22,088 | $54.41 | 2,269,675 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-12-11 | 200 | $54.99 | 2,269,475 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-12-08 | 5,032 | $0.00 | 2,291,763 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2023-12-08 | 26,555 | $0.00 | 26,555 | $54.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,555 | 2023-12-08 | 2030-12-08 | No | 4 | A | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $53.94 to $54.79. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $54.96 to $55.03. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
- The exercise price of this option to the extent it is an incentive stock option is $60.12 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $54.65 per share.
- This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.
- The expiration date of this option to the extent it is an incentive stock option is 12/8/2028, and the expiration date of this option to the extent it is a nonqualified stock option is 12/8/2030.
Billionaire Hedge Funds
